{{Drugbox
| IUPAC_name = 1-(2,3-dihydro-1,4-benzodioxin-8-yl)piperazine
| image = Eltoprazine.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 98224-03-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 65853
| ChemSpiderID = 59265
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 510M006KO6
| ChEMBL = 282614

<!--Chemical data-->
| C=12 | H=16 | N=2 | O=2 
| molecular_weight = 220.121 g/mol
| smiles = C1CN(CCN1)C2=C3C(=CC=C2)OCCO3
}}

'''Eltoprazine''' ('''DU-28,853''') is a [[drug]] of the [[phenylpiperazine]] class which is a [[serenic]] or anti[[aggressive]] agent.<ref name="pmid2091890">{{cite journal | vauthors = Olivier B, Mos J, Rasmussen D | title = Behavioural pharmacology of the serenic, eltoprazine | journal = Drug Metabol Drug Interact. | volume = 8 | issue = 1-2 | pages = 31–83 | year = 1990 | pmid = 2091890 | doi=10.1515/DMDI.1990.8.1-2.31}}</ref> It acts as an [[agonist]] at the [[5-HT1A|5-HT<sub>1A</sub>]] and [[5-HT1B|5-HT<sub>1B</sub>]] receptors and as an [[antagonist]] at the [[5-HT2C|5-HT<sub>2C</sub>]] receptor.<ref name="pmid1982626">{{cite journal | vauthors = Schipper J, Tulp MT, Sijbesma H | title = Neurochemical profile of eltoprazine. | journal = Drug Metabol Drug Interact. | volume = 8 | issue = 1-2 | pages = 85–114 | year = 1990 | pmid = 1982626 | doi=10.1515/dmdi.1990.8.1-2.85}}</ref> It is closely related to [[fluprazine]] and [[batoprazine]], which are similarly acting drugs.

It is also a known precursor to [[S-15535]] & [[Lecozotan]].
== See also ==
* [[Phenylpiperazine]]

== References ==
{{Reflist}}

{{Serenics}}
{{Serotonergics}}
{{Piperazines}}

[[Category:5-HT2C antagonists]]
[[Category:Piperazines]]
[[Category:Serotonin receptor agonists]]
[[Category:Benzodioxins]]